Overview

Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.

Status:
Terminated
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this multi-center study is to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established (appendicular skeletal) non union fractures, when used with one of the commonly employed commercially available allograft chip matrices.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vericel Corporation